Work

Type 2 diabetes, glucose, insulin, BMI, and ischemic stroke subtypes: Mendelian randomization study

Year: 2017
Type: article
Study design: Observational Study
Abstract: Objective: To implement a mendelian randomization (MR) approach to determine whether type 2 diabetes mellitus (T2D), fasting glucose, fasting insulin, and body mass index (BMI) are causally associated with specific ischemic stroke subtypes. Methods: MR estimates of the association between each possible risk factor and ischemic stroke subtypes were calculated with inverse-variance weighted (conventional) and weighted median approaches, and MR-Egger regression was used to explore pleiotropy. The number of single nucleotide polymorphisms (SNPs) used as instrumental variables was 49 for T2D, 36 for fasting glucose, 18 for fasting insulin, and 77 for BMI. Genome-wide association study data of SNP-stroke associations were derived from METASTROKE and the Stroke Genetics Network (n = 18,476 ischemic stroke cases and 37,296 controls). Results: Conventional MR analysis showed associations between genetically predicted T2D and large artery stroke (odds ratio [OR] 1.28, 95% confidence interval [CI] 1.16–1.40, p = 3.3 × 10−7) and small vessel stroke (OR 1.21, 95% CI 1.10–1.33, p = 8.9 × 10−5) but not cardioembolic stroke (OR 1.06, 95% CI 0.97–1.15, p = 0.17). The association of T2D with large artery stroke but not small vessel stroke was consistent in a sensitivity analysis using the weighted median method, and there was no evidence of pleiotropy. Genetically predicted fasting glucose and fasting insulin levels and BMI were not statistically significantly associated with any ischemic stroke subtype. Conclusions: This study provides support that T2D may be causally associated with large artery stroke.
Source: Neurology
Language: English
Subfield: Genetics
Open Access status: bronze
Awards: G1007715963, G1044594144, WTCCC2 core activities., Aetiology of type 2 diabetes and related metabolic disorders, UC Davis Alzheimer's Disease Core Center, CHARGE: Identifying Risk & Protective SNV for AD in ADSP Case-control Sample, High Throughput Science - Investigating the genetic determinants of healthy ageing: the MRC EPIC-Norfolk study, NIHR Senior Investigator Award, G2146332128, WTCCC2 core activities, M D Anderson Cancer Center Head & Neck SPORE, Molecular Epidemiology of DNA Repair in Head and Neck Cancer, A Genome-wide Association Study for Early-Onset Myocardial Infarction, G3156332283, Pharmacogenomic, genetic and trial-based studies of lipid-modifying therapies and vascular risk, Statistical Methods for Gene Environment Interactions In Lung Cancer, Randomized Clinical Trials - Whole Genome Studies Coordinating Center, G3803372573, G3812975344, Genome-wide association study in stroke, The Baltimore Longitudinal Study Of Aging, Genome Wide Association Coordinating Center, G4700852728, Genetics Of Stroke, A Center for GEI Association Studies, Pharmacogenomic studies in VISP: results & implications for clinical trial design, Genetic Risk to Stroke in Smokers and Nonsmokers in Two Ethnic Groups, An NCRR Center for High Throughput SNP Genotyping and Analysis, Genetic Predictors for DNA Repair Phenotype in CMM, Mid-Atlantic Nutrition Obesity Research Center, G7093047072, GWAS of Hormone Treatment and CVD and Metabolic Outcomes in the WHI, WTCCC2 core activities., G8267674335, Vitamin Intervention for Stroke Prevention (VISP), Genetics of Early Onset-Stroke, The NINDS International Stroke Genetics Consortium Study, Precursors of Stroke Incidence and Prognosis, The University of Texas M. D. Anderson Cancer Center SPORE in Melanoma
OpenAlex ID: W2725404076
FWCI: 5.125
Cites: 41
Cited by: 129
Related to: 8